Clinical Trials
Academic Medical Center System Infrastructure Trends and Related Challenges for Conducting Clinical Trials
Though academic medical centers (AMCs) may differ widely—public vs private, city vs rural, and system infrastructure and resource variations—they generally share the same tripartite mission: research, medical education, and patient care. Yet, increasingly, complex clinical research systems and processes...
Clinical Trials
Parexel Expands Phase I Research Capabilities in Greater China region with New Early Phase Clinical Unit Alliances
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization, announced it has formed alliances with three prominent healthcare institutions. PKUCare Luzhong Hospital, West...
Clinical Trials
Sharp’s Netherlands Facility Approved for Clinical Operations
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen,...
Clinical Trials
Catalent To Open New Clinical Supply Facility In San Diego
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced it is to invest $9 million in a new clinical supply facility in San Diego, due...
Clinical Trials
Velesco Pharma set for clinical manufacturing capacity expansion
Pharmaceutical development and clinical manufacturing expert, Velesco Pharma, is set to triple its clinical manufacturing capacity with the purchase and fit-out of a new, state-of-the-art facility in Wixom, Michigan.
The new building will feature expanded processing suite space to provide...
Clinical Trials
Tagrisso approved in China as a 1st line treatment for EGFR mutated non-small cell lung cancer
AstraZeneca announced that it has received marketing authorisation from China’s National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults with locally-advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have the genetic mutations...
Clinical Trials
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.